Prostate cancer patients inform health economics research
CHÉOS Scientists are testing the cost-effectiveness of adding a new blood test to improve prostate cancer screening
Read MoreMarch 12, 2021
CHÉOS investigators are at the forefront of health outcomes research, including health economics, pharmacoeconomics and patient-reported outcomes. Their work evaluates the effectiveness of health interventions in populations to inform policies, transforming health systems at the local, national and international levels in the future.
CHÉOS Scientists are testing the cost-effectiveness of adding a new blood test to improve prostate cancer screening
Read More
As we adjust our clocks for Daylight Saving Time, Dr. Annalijn Conklin and Kexin Zhang discuss some of the longer-term impacts of sleep disturbance on health
Read More
Paramedics are the focus of a new COVID-19 study, led by CHÉOS Scientist Dr. Brian Grunau
Read More
A new investigation from the CHÉOS Health Economics Program indicates the framework could speed up generic entry to Canadian public health plans
Read More
New study led by CHÉOS Scientist Dr. Anne Gadermann will explore the impact COVID-related school disruptions have had on student and teacher wellbeing
Read More
CHÉOS Scientist Dr. Christopher Fordyce chaired the writing of a new American Heart Association Scientific Statement, “Prevention of Complications in the Cardiac Intensive Care Unit”
Read More